Toward magnetic resonance imaging biomarkers for progressive supranuclear palsy and multisystem atrophy

Movement Disorders

Volumn 27, Issue 14, 2012, Pages 1711-1713

  Sauvaget, Frederic ^a,b,c   Litvan, Irene ^c  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY DIAGNOSIS; EDITORIAL; ELECTROENCEPHALOGRAM; FOLLOW UP; FRACTIONAL ANISOTROPY; HUMAN; MAGNETOENCEPHALOGRAPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME;

BRAIN MAPPING; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SYSTEM ATROPHY; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84871755391     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25196     Document Type: Editorial

References (18)

1. Serenó L, Coma M, Rodríguez M, et al. A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Neurobiol Dis 2009; 35: 359-367.
2. Ubhi K, Inglis C, Mante M, et al. Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy. Exp Neurol 2012; 234: 405-416.
3. Zhang B, Carroll J, Trojanowski JQ, et al. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci 2012; 32: 3601-3611.
4. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18: 467-486.
5. Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain 2007; 130: 1552-1565.
6. Payan CAM, Viallet F, Landwehrmeyer BG, et al. Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale. PLoS One 2011; 6: e22293.
7. Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214-221.
8. Rolland Y, Vérin M, Payan CA, et al. A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry 2011; 82: 1025-1032.
9. Massey LA, Micallef C, Paviour DC, et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012 Apr 4. doi: 10.1002/mds.24968.
10. Whitwell JL, Xu J, Mandrekar J, et al. Imaging measures predict progression in progressive supranuclear palsy. Mov Disord 2012 Mar 13. doi: 10.1002/mds.24970.
11. Teune LK, Bartels AL, de Jong BM, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 2010; 25: 2395-2404.
12. Messina D, Cerasa A, Condino F, et al. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. Parkinsonism Relat Disord 2011; 17: 172-176.
13. Padovani A, Borroni B, Brambati SM, et al. Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2006; 77: 457-463.
14. Gong G, He Y, Concha L, et al. Mapping anatomical connectivity patterns of human cerebral cortex using in vivo diffusion tensor imaging tractography. Cereb Cortex 2009; 19: 524-536.
15. Van Essen DC, Ugurbil K. The future of the human connectome. Neuroimage 2012; 62: 1299-1310.
16. Mahlknecht P, Hotter A, Hussl A, et al. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis 2010; 7: 300-318.
17. Whitwell JL, Avula R, Master A, et al. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord 2011; 17: 599-605.
18. Stam CJ. Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders. J Neurol Sci 2010; 289: 128-134.